Hanmi Pharmaceutical Company Limited

This early-phase study tests an experimental drug called HM16390, given alone or with the immunotherapy pembrolizumab, in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to find safe doses and check for early sign…

This study tests a new drug called HM11260C for adults with type 2 diabetes whose blood sugar is still too high despite taking metformin and dapagliflozin. About 118 participants will receive either the new drug or a placebo for 36 weeks to see if it safely lowers HbA1c levels. T…

This early-phase study tests a new drug called BH3120, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug shrinks tumors. About 245 adults with P…

This study tests a combination of two oral drugs, belvarafenib and cobimetinib, in people with advanced melanoma that has a specific NRAS gene mutation. The goal is to see if the combination can shrink tumors and control the disease. About 45 adults whose cancer has not responded…

This early-stage study is testing a new drug called HM17321 in healthy and obese adults to see if it is safe and how the body processes it. About 90 participants will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood,…

This study tests an experimental drug called HM15912 (sonefpeglutide) in 18 adults with short bowel syndrome who need IV nutrition. The goal is to see if the drug is safe and can help the intestines absorb more nutrients, potentially reducing the need for IV support. Participants…